Comparing oxygen levels during surgery in older patients
Official title: Effects of Different Inhaled Oxygen Concentrations on Lung Function in Older Patients After Laparoscopic Gastrointestinal Surgery Under General Anesthesia
Run by China Medical University, China · NCT06359106 · Data updated 2026-11-12
This study is testing whether giving older patients different levels of oxygen during laparoscopic surgery can improve their lung function and reduce complications after the procedure.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 1176 (estimated) |
| Sponsor | China Medical University, China Academic / other |
| Locations | 16 sites (Shenyang, Liaoning and 15 other locations) |
| Status | Recruiting |
| Started | July 2, 2024 |
| Main results expected | June 30, 2026 |
| Study ends | June 30, 2026 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT06359106 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are older adults aged 65 and above who are scheduled for laparoscopic gastrointestinal surgery and meet specific health criteria.
✕Probably not a fit
Patients with severe respiratory or cardiac conditions, or those requiring intensive care post-surgery, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effects of different inhaled oxygen concentrations (40% vs. 80%) on lung function in older patients undergoing laparoscopic gastrointestinal surgery. The study is a multicenter, randomized controlled trial involving 1098 subjects aged over 65 years, who will be assigned to receive either low or high levels of oxygen during surgery. The primary outcome measure is the oxygenation index assessed 48 hours postoperatively, while secondary outcomes include postoperative pulmonary complications and mortality rates within 30 days. The study employs a lung-protective ventilation strategy to optimize respiratory parameters during the procedure.
Why it matters
Potential benefit: If successful, this study could improve postoperative lung function and reduce complications in older patients undergoing surgery.
How similar studies have gone: Previous studies have shown varying results with different oxygen concentrations, but this specific approach in older surgical patients is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age not less than 65 years * American Society of Anesthesiologists grades I-III * No history of drug allergies or abnormal anesthesia. * The duration of mechanical ventilation was expected to be more than 2 hours. * Laparoscopic Gastrointestinal Surgery * The preoperative oxygen saturation was not less than 94%. * The patients will be planned to extubate in the operating room. Exclusion Criteria: * History of acute lung injury or acute respiratory distress syndrome (ARDS) within 3 months. * Cardiac function Class IV (New York Heart Association classification) * Chronic renal failure (renal cell filtration rate \<30 ml min-11.73/m2), severe liver disease * Patients with blurred consciousness and cognitive dysfunction * Severe coagulation dysfunction. * Without preoperative oxygen inhalation, blood oxygen level \<94%, and severe pulmonary dysfunction * Patients with endotracheal tubes were admitted to the intensive care unit (ICU) after surgery. * Body mass index (BMI) \>30kg/m2 * Inability to complete the study
Where it's running
-
the First Hospital of China Medical University
Shenyang, Liaoning, China Recruiting -
Beijing Friendship Hospital, Capital Medical University
Beijing, China Recruiting -
Sichuan Provincial People's Hospital
Chendu, China Recruiting -
Chifeng Municipal Hospital
Chifeng, China Recruiting -
Dalian Third People's Hospital
Dalian, China Recruiting -
First Affiliated Hospital, Dalian Medical University
Dalian, China Recruiting
Show 10 more locations
-
First Affiliated Hospital of Harbin Medical University
Harbin, China Recruiting -
Harbin Medical University Cancer Hospital
Harbin, China Recruiting -
First Medical University and Shandong Provincial Qianfoshan Hospital
Jinan, China Recruiting -
First Affiliated Hospital of Kunming Medical University
Kunming, China Recruiting -
Affiliated Hospital of Qingdao University
Qingdao, China Recruiting -
Liaoning Cancer Hospital and Institute
Shenyang, China Recruiting -
Shenzhen People's Hospita
Shenzhen, China Recruiting -
First Hospital of Hebei Medical University
Shijia Zhuang, China Recruiting -
Second Hospital of Hebei Medical University
Shijia Zhuang, China Recruiting -
YANBIAN University Hospital(Yanbian Hospital)
Yanbian, China Recruiting
Study contacts
- Study coordinator: Tianhao Zhang, M.D.
- Email: zhth774176947@163.com
- Phone: +862483283100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Risks of lung-opening maneuvers and PEEP adjustments in ventilated children
This project will track how often lung-opening maneuvers and PEEP adjustments cause complications in children under 14 who are on mechanical ventilation in the PICU.
-
Binaural beats for cognitive function in older adults with mild cognitive impairment in nursing homes
This study tests whether listening to 10-Hz binaural beats for 30 minutes daily for 14 days can help cognitive function in older adults with mild cognitive impairment living in nursing homes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
-
Pathogenesis and Reversal Strategies for Cancer Cachexia Using Multi-Omics
This study uses multiple omics methods and nutritional interventions to try to find causes and reversal strategies for cachexia in adults with gastrointestinal cancers.
-
Trastuzumab plus serplulimab with chemotherapy for HER2-positive advanced biliary tract or urothelial cancer after prior therapy
This study will test whether adding trastuzumab and serplulimab to chemotherapy helps people with HER2-positive unresectable or metastatic biliary tract cancer or urothelial carcinoma who have not responded to standard treatment.
-
Chidamide plus PD-L1 inhibitor with carboplatin and etoposide for first-line extensive-stage small‑cell lung cancer
This trial will test whether adding chidamide to a PD-L1 inhibitor together with carboplatin and etoposide helps people with extensive-stage small‑cell lung cancer stay progression‑free longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.